Medication & Safety
How Much Does Ozempic Cost? A Country-by-Country Guide
Ozempic costs $800–$1000 per month in the US without insurance. Costs vary widely globally. Here is the complete breakdo...
The evidence strongly suggests that semaglutide works best as a long-term medication, not a short-term course. Weight loss on semaglutide is maintained only as long as the drug is active in the body. When treatment stops, the appetite-suppressing signals stop, and for most patients, weight gradually returns.
This is not a failure of willpower. It reflects the biological reality of obesity as a chronic condition requiring ongoing management — the same way blood pressure medication needs to be taken continuously, not just until blood pressure normalises.
What Happens When You Stop Semaglutide
The STEP 4 trial directly tested what happens when semaglutide is stopped after weight loss. After 48 weeks of treatment, participants had lost an average of 10.6% of body weight. Those who continued for another 48 weeks lost an additional 7.9% (total 17.5%). Those who switched to placebo regained most of what they lost, with the majority returning to near their starting weight by week 120.
Two years after stopping, the weight loss was largely gone. Hunger and food reward signalling returned to pre-treatment levels because the drug that was suppressing them was no longer present.
What the Clinical Guidelines Say
The major diabetes and obesity medical associations — the American Diabetes Association, Obesity Medicine Association, and European equivalents — classify obesity as a chronic disease. Their guidance on semaglutide and similar GLP-1 agonists reflects this: these are recommended as long-term maintenance medications for people who respond to them, not finite treatment courses.
The minimum treatment duration to assess response is typically 16 to 20 weeks. If meaningful weight loss (greater than 5%) has not occurred by this point, physicians reassess whether the medication is working for that individual.
When Stopping Makes Sense
Not everyone needs to continue indefinitely. Reasonable circumstances for stopping include:
Sustained weight loss with lifestyle change: Some patients use semaglutide for 12 to 24 months to establish new eating habits, achieve significant weight loss, and then maintain through consistent diet and exercise changes. This works for a minority of patients who have fundamentally changed their relationship with food during treatment.
Pregnancy: Semaglutide is not recommended during pregnancy. Patients planning pregnancy should discuss a stopping timeline with their physician.
Side effects that do not resolve: Persistent severe nausea or other adverse effects that significantly reduce quality of life may justify stopping and considering alternative approaches.
Cost and access: For many patients, the cost of long-term semaglutide is the primary limiting factor. When stopping is a financial decision, the strategy should include a clear maintenance plan to slow weight regain as much as possible.
Reducing Regain After Stopping
If semaglutide is stopped, the rate of weight regain is influenced by several factors:
A high-protein diet slows weight regain by preserving lean mass and supporting satiety through non-pharmaceutical means. Regular resistance training maintains metabolic rate. Limiting ultra-processed foods and refined carbohydrates reduces the appetite surges that typically drive rapid regain after stopping.
These measures slow regain; they rarely prevent it entirely.
A Structured Programme Approach
Some patients approach GLP-1 treatment as a time-limited programme rather than indefinite medication — similar to how METASLIM's physician-guided 8-week program is structured. A defined programme timeline (8 weeks) with clear goals and physician oversight can produce meaningful results while managing cost and establishing behavioural changes that extend the benefit beyond the programme period.